Skip to Main Content

Paper Details

Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field.
Lung Cancer
7
2021
Author NameAffiliation
Anna-Lena VolckmarInstitute of Pathology, University Hospital Heidelberg
Martina KirchnerInstitute of Pathology, University Hospital Heidelberg
Michael Allg??uerInstitute of Pathology, University Hospital Heidelberg
Olaf NeumannInstitute of Pathology, University Hospital Heidelberg
Jan BudcziesInstitute of Pathology, University Hospital Heidelberg, Germany Institute of Pathology, Charite Universitatsmedizin Berlin
Peter HorakNational Center for Tumor Diseases (NCT) Heidelberg, and German Cancer Research Center (DKFZ)
Huriye Seker-CinInstitute of Pathology, University Hospital Heidelberg
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg, and German Cancer Research Center (DKFZ)
Peter SchirmacherInstitute of Pathology, University Hospital Heidelberg
Volker EndrisInstitute of Pathology, University Hospital Heidelberg
Daniel KazdalInstitute of Pathology, University Hospital Heidelberg, Germany Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL)
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg, Germany Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL)
  • 1 - 12

Datasets